Close

Medicinova (MNOV) Announces Presentation of MN-166 Phase 2 Data in Opioid Dependence

February 8, 2016 9:26 AM EST Send to a Friend
MediciNova, Inc (NASDAQ: MNOV) announced that principal investigator Sandra Comer, Ph.D., Professor, Department of Psychiatry, Columbia University and New York ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login